Core Viewpoint - A class action lawsuit has been filed against Bakkt Holdings, Inc. for alleged violations of federal securities laws, specifically regarding misleading statements about the stability of its crypto business and revenue diversity [1] Group 1: Lawsuit Details - The lawsuit pertains to shareholders who purchased Bakkt's securities between March 25, 2024, and March 17, 2025 [1] - The complaint claims that Bakkt misrepresented the stability of its crypto business and the diversity of its revenue streams [1] - It is alleged that Bakkt failed to disclose its significant reliance on a contract with Webull for its crypto revenues [1] Group 2: Investor Impact - Shareholders who suffered losses during the class period are encouraged to contact the DJS Law Group to participate in the lawsuit [2] - The DJS Law Group specializes in securities class actions and aims to enhance investor returns through advocacy [3]

Core Viewpoint - A class action lawsuit has been filed against SoundHound AI, Inc. for violations of federal securities laws, specifically related to misleading statements and weaknesses in financial reporting controls [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that SoundHound made false and misleading statements to the market, particularly regarding its internal controls over financial reporting [2]. - The company is accused of overstating its remediation of internal control weaknesses and inflating reported goodwill following its acquisition of Amelia [2]. - Delays in accounting for acquisitions, including those of Amelia and SYNQ3, led to the company's failure to file certain financial reports with the SEC on time [2]. Group 2: Shareholder Information - Shareholders who purchased securities between May 10, 2024, and March 3, 2025, are encouraged to contact the law firm to participate in the class action [1][3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - A lawsuit is pending against Pacira BioSciences, Inc. for alleged violations of securities laws related to misleading statements about patent protections for Exparel, which is critical for the company's revenue growth [2]. Group 1: Lawsuit Details - An investor filed a lawsuit on January 13, 2025, claiming that Pacira made false statements regarding the patent protections for Exparel, which accounts for approximately 80% of the company's revenue [2]. - The lawsuit alleges that Pacira misrepresented the strength of the '495 patent, which was invalidated in a separate case, leading to concerns that generic competition could arise during the patent's life [2]. Group 2: Investor Information - Shareholders who purchased shares of Pacira BioSciences, Inc. prior to August 2023 and continue to hold them are encouraged to contact the Shareholders Foundation for options regarding the lawsuit [1][3].

Core Viewpoint - A lawsuit is pending against Manhattan Associates, Inc. for alleged violations of securities laws, with claims that the company misled investors regarding its revenue outlook and growth potential [2]. Group 1: Lawsuit Details - The lawsuit was filed by an investor on February 25, 2025, alleging that Manhattan Associates made false and misleading statements about its financial health and growth prospects [2]. - The plaintiff claims that the company created a false impression of having reliable information about its projected revenue and growth while downplaying risks associated with seasonality and macroeconomic fluctuations [2]. - It is asserted that the company's optimistic reports on growth in its professional services did not align with the actual performance, particularly in light of macroeconomic challenges [2]. Group 2: Investor Information - Shareholders who purchased shares of Manhattan Associates prior to October 2024 and continue to hold them are encouraged to contact the Shareholders Foundation for options regarding the lawsuit [1][3]. - The Shareholders Foundation provides services related to shareholder issues, including information on securities class actions and legal news relevant to the financial market [3].

SAN DIEGO, April 30, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) prior to October 2022 and continue to hold any of thoseNYSE: ATNM shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.On March 27, 2025, aNYSE: ATNM investor filed a lawsuit agai ...